Clinical Trial

Endometrioma Sclerotherapy and Ovarian Preservation

Study acronym: ENDOSAVE
Recruiting
View on ClinicalTrials.gov →
Summary
A randomised controlled trial assessing ovarian reserve after laparoscopic ethanol sclerotherapy of ovarian endometrioma compared to standard treatment of surgical excision of endometrioma. Secondary outcomes will include endometrioma recurrence, symptomatology and inflammatory environment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-09; most recent amendment 2025-11-24.
Status change: Not Yet Recruiting → Recruiting 2025-04-17
Trial Details
NCT Number NCT06775769
Lead Sponsor Chelsea and Westminster NHS Foundation Trust
Conditions Endometrioma
Enrollment 60 participants
Start Date 2025-02-21
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-25